Kronos Bio, Inc. (KRON) announced on Wednesday that it has appointed CFO and COO Deborah Knobelman as president and interim chief executive officer, with effect from December 3.
In addition, Kronos has announced a workforce reduction of around 83 percent by year-end to cut costs.
Deborah will succeed Norbert Bischofberger, who will remain on the Board and continue to serve as an advisor.
The drug maker noted that it is also exploring options, including possible business combinations or divestiture of its remaining internally developed preclinical assets to boost stockholder value.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.